1. Next-Generation Sequencing in Myeloproliferative Neoplasms: Is This Indicated in All Patients?

   • Alain Antoine Mina
   • Brady Stein

   Myeloproliferative Neoplasms (B Stein, Section Editor) 30 April 2019 Pages: 137 - 144

2. Key Role of Inflammation in Myeloproliferative Neoplasms: Instigator of Disease Initiation, Progression. and Symptoms

   • Laura F. Mendez Luque
   • Amanda L. Blackmon
   • Angela G. Fleischman

   Myeloproliferative Neoplasms (B Stein, Section Editor) 22 May 2019 Pages: 145 - 153

   

3. Chronic Myelomonocytic Leukemia: 2018 Update to Prognosis and Treatment

   • Hany Elmariah
   • Amy E. DeZern

   Myeloproliferative Neoplasms (B Stein, Section Editor) 15 May 2019 Pages: 154 - 163

   

4. Integrative Approaches to Managing Myeloproliferative Neoplasms: the Role of Nutrition, Exercise, and Psychological Interventions

   • Prathibha Surapaneni
   • Robyn M. Scherber

   Myeloproliferative Neoplasms (B Stein, Section Editor) 15 May 2019 Pages: 164 - 170

   

5. Trends in Clinical Benefits and Costs of Novel Therapeutics in AML: at What Price Does Progress Come?

   • Jennifer E. Vaughn
   • Veena Shankaran
   • Roland B. Walter

   Health Economics (N Khera, Section Editor) 11 May 2019 Pages: 171 - 178

6. Disparities in Survival and Health Outcomes in Childhood Leukemia

   • Lena E. Winestone
   • Richard Aplenc

   Health Economics (N Khera, Section Editor) 09 May 2019 Pages: 179 - 186

   

7. Expert Panel Consensus Statement for Proper Evaluation of First Relapse in Multiple Myeloma

   • M. Offidani
   • M. Boccadoro
   • M. Cavo

   Multiple Myeloma (P Kapoor, Section Editor) 10 May 2019 Pages: 187 - 196

   

8. Targeting BTK in CLL: Beyond Ibrutinib

   • David A. Bond
   • Jennifer A. Woyach

   ReviewPaper 27 April 2019 Pages: 197 - 205